Hematologic Cancers

Leslie Lauersdorf discusses the need to balance optimism and realism in caring for patients with relapsed/refractory multiple myeloma.
Tiffany Richards explains the difficulties she has encountered in managing patients who have battled myeloma for an extended period of time and have experienced multiple relapses.
Tiffany Richards provides an overview of the most common questions she hears from patients regarding daratumumab.
Beth Faiman expresses her main concerns regarding new treatments being studied to treat multiple myeloma.
Tiffany Richards expresses her positive outlook on daratumumab, citing that the treatment has helped extend life expentancies.
Leslie Lauersdorf insist that it's vital to inform your patients about what's involved in beginning daratumumab treatments, especially because of the lengthy chair time.
Beth Faiman identifies how the Janssen CarePath program can financially help anyone who is diagnosed with multiple myeloma and requires daratumumab.
Leslie Lauersdorf notes that having patients assist in managing their own side effects is important to help them stay on treatment and improve their quality of life.
Tiffany Richards insists on the importance of survivorship care in patients with multiple myeloma and explains how to make sure patients stay as healthy as possible for as long as possible.
Tiffany Richards is excited about all the new multiple myeloma treatments that are being introduced, but understands that the question of how to best utilize these drugs still remains to be answered.
Page 1 of 3
Results 1 - 10 of 27